Login / Signup

Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study.

Matthias PreusserTomáš KazdaEmilie Le RhunFelix SahmMarion SmitsJens GemptJohan Af KoekkoekAngelo F MontiMarcell CsanadiJános György PitterHelen BulbekBeatrice FournierCaroline QuoilinThierry GorliaMichael WellerGiuseppe Minnitinull null
Published in: Trials (2024)
ClinicalTrials.gov NCT05904119. Registered before start of inclusion, 23 May 2023.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • phase ii
  • double blind
  • randomized controlled trial